Annual Total Debt
$18.86 M
+$4.42 M+30.58%
December 31, 2024
Summary
- As of March 12, 2025, KROS annual total debt is $18.86 million, with the most recent change of +$4.42 million (+30.58%) on December 31, 2024.
- During the last 3 years, KROS annual total debt has risen by +$17.77 million (+1625.62%).
- KROS annual total debt is now at all-time high.
Performance
KROS Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$18.86 M
-$425.00 K-2.20%
December 31, 2024
Summary
- As of March 12, 2025, KROS quarterly total debt is $18.86 million, with the most recent change of -$425.00 thousand (-2.20%) on December 31, 2024.
- Over the past year, KROS quarterly total debt has stayed the same.
- KROS quarterly total debt is now -2.20% below its all-time high of $19.29 million, reached on September 30, 2024.
Performance
KROS Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
KROS Total Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +30.6% | 0.0% |
| 3 y3 years | +1625.6% | +1625.6% |
| 5 y5 years | +1379.3% | +1379.3% |
KROS Total Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1625.6% | -2.2% | +4045.3% |
| 5 y | 5-year | at high | +1998.0% | -2.2% | +4045.3% |
| alltime | all time | at high | +2293.5% | -2.2% | -100.0% |
Keros Therapeutics Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $18.86 M(+30.6%) | $18.86 M(-2.2%) |
| Sep 2024 | - | $19.29 M(+38.2%) |
| Jun 2024 | - | $13.96 M(-1.7%) |
| Mar 2024 | - | $14.20 M(-1.7%) |
| Dec 2023 | $14.44 M(+8.9%) | $14.44 M(+0.9%) |
| Sep 2023 | - | $14.31 M(+2.6%) |
| Jun 2023 | - | $13.95 M(-0.3%) |
| Mar 2023 | - | $13.99 M(+5.5%) |
| Dec 2022 | $13.27 M(+1113.7%) | $13.27 M(+2815.6%) |
| Sep 2022 | - | $455.00 K(-32.1%) |
| Jun 2022 | - | $670.00 K(-24.2%) |
| Mar 2022 | - | $884.00 K(-19.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $1.09 M(+21.6%) | $1.09 M(-15.7%) |
| Sep 2021 | - | $1.30 M(+87.6%) |
| Jun 2021 | - | $691.00 K(-13.3%) |
| Mar 2021 | - | $797.00 K(-11.3%) |
| Dec 2020 | $899.00 K(-29.5%) | $899.00 K(-9.9%) |
| Sep 2020 | - | $998.00 K(-8.6%) |
| Jun 2020 | - | $1.09 M(-7.8%) |
| Mar 2020 | - | $1.19 M(-7.1%) |
| Dec 2019 | $1.27 M(+61.8%) | $1.27 M(>+9900.0%) |
| Sep 2019 | - | $0.00(0.0%) |
| Jun 2019 | - | $0.00(0.0%) |
| Mar 2019 | - | $0.00 |
| Dec 2018 | $788.00 K | - |
FAQ
- What is Keros Therapeutics annual total debt?
- What is the all time high annual total debt for Keros Therapeutics?
- What is Keros Therapeutics annual total debt year-on-year change?
- What is Keros Therapeutics quarterly total debt?
- What is the all time high quarterly total debt for Keros Therapeutics?
- What is Keros Therapeutics quarterly total debt year-on-year change?
What is Keros Therapeutics annual total debt?
The current annual total debt of KROS is $18.86 M
What is the all time high annual total debt for Keros Therapeutics?
Keros Therapeutics all-time high annual total debt is $18.86 M
What is Keros Therapeutics annual total debt year-on-year change?
Over the past year, KROS annual total debt has changed by +$4.42 M (+30.58%)
What is Keros Therapeutics quarterly total debt?
The current quarterly total debt of KROS is $18.86 M
What is the all time high quarterly total debt for Keros Therapeutics?
Keros Therapeutics all-time high quarterly total debt is $19.29 M
What is Keros Therapeutics quarterly total debt year-on-year change?
Over the past year, KROS quarterly total debt has changed by $0.00 (0.00%)